Literature DB >> 23765113

Impact of early graft function on 10-year graft survival in recipients of kidneys from standard- or expanded-criteria donors.

Nassima Smail1, Jean Tchervenkov, Steven Paraskevas, Dana Baran, Istvan Mucsi, Mazen Hassanain, Prosanto Chaudhury, Marcelo Cantarovich.   

Abstract

BACKGROUND: The use of kidneys from expanded-criteria donors (ECD) is regarded with caution.
METHODS: We compared 279 kidney transplant recipients (KTxR) from standard-criteria donors (SCD) and 237 from ECD, transplanted between January 1990 and December 2006. We evaluated the impact of immediate graft function (IGF), slow graft function (SGF), and delayed graft function (DGF) and the drop in estimated glomerular filtration rate (ΔeGFR) ≤ 30% or > 30% during the first year after transplantation on long-term patient and death-censored graft survival (DCGS).
RESULTS: Ten-year patient survival was similar in SCD- or ECD-KTxR (P = 0.38). DCGS was better in SCD-KTxR versus ECD-KTxR (77.3% vs. 67.3%; P = 0.01). DCGS did not differ in either group experiencing IGF (P = 0.17) or DGF (P = 0.12). However, DCGS was worse in ECD-KTxR experiencing SGF (84.9% vs. 73.7%; P = 0.04). Predictors of DCGS were 1-year serum creatinine (hazard ratio, 1.03; P < 0.0001) and ΔeGFR > 30% between 1 and 12 months (Δ1-12eGFR) after transplantation (hazard ratio, 2.2; P = 0.02). In ECD-KTxR with IGF and more than 1-year follow-up, 10-year DCGS was better in those with Δ1-12eGFR ≤ 30% versus those with Δ1-12eGFR > 30% (83.8% vs. 53.6%; P = 0.01).
CONCLUSION: Recipients of SCD or ECD kidneys with IGF or DGF had similar 10-year patient survival and DCGS. SGF had a worse impact on DCGS in ECD-KTxR. In addition to 1-year serum creatinine, Δ1-12eGFR > 30% is a negative predictor of DCGS. Larger studies should confirm if increasing the use of ECD, avoiding factors that contribute to SGF or DGF, and/or a decline in eGFR during the first year after transplantation may expand the donor pool and result in acceptable long-term outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23765113     DOI: 10.1097/TP.0b013e318297443b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Expanding the use of expanded criteria donors in kidney transplantation.

Authors:  Luciana Assis-Borba; Marina P Cristelli; Mayara I Paula; Marcelo F Franco; Helio Tedesco-Silva; Jose O Medina-Pestana
Journal:  Int Urol Nephrol       Date:  2014-03-28       Impact factor: 2.370

2.  Delayed Graft Function Phenotypes and 12-Month Kidney Transplant Outcomes.

Authors:  Isaac E Hall; Peter P Reese; Mona D Doshi; Francis L Weng; Bernd Schröppel; William S Asch; Joseph Ficek; Heather Thiessen-Philbrook; Chirag R Parikh
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

3.  Ex-vivo partial nephrectomy after living donor nephrectomy: Surgical technique for expanding kidney donor pool.

Authors:  Yaw A Nyame; Paurush Babbar; Ahmed A Aboumohamed; Ryan L Mori; Stuart M Flechner; Charles S Modlin
Journal:  Urol Ann       Date:  2017 Jan-Mar

4.  Clinical relevance of cell-free mitochondrial DNA during the early postoperative period in kidney transplant recipients.

Authors:  Kipyo Kim; Haena Moon; Yu Ho Lee; Jung-Woo Seo; Yang Gyun Kim; Ju-Young Moon; Jin Sug Kim; Kyung-Hwan Jeong; Tae Won Lee; Chun-Gyoo Ihm; Sang-Ho Lee
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

5.  EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial.

Authors:  Sophie Girerd; Luc Frimat; Didier Ducloux; Yannick Le Meur; Christophe Mariat; Bruno Moulin; Christiane Mousson; Philippe Rieu; Nassim Dali-Youcef; Ludovic Merckle; Xavier Lepage; Patrick Rossignol; Nicolas Girerd; Frédéric Jaisser
Journal:  Trials       Date:  2018-10-30       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.